Immune Pharmaceuticals Appoints COO

Immune Pharmaceuticals Appoints COO

Immune Pharmaceuticals was out Monday with a business update and financial highlights for Q2. Dr. Tony Fiorino has joined the company as Chief Medical Officer and Chief Operating Officer. The company said its oncology spin-off, Cytovia, has named Daniel Teper as Chief Executive Officer, with Rama Rao, a former Novartis (NVS) executive, being appointed as Cytovia’s interim Chief Financial Officer and Chief Operating Officer. The company says Cytovia anticipates applying […]

Read More ˃
Archrock Upgraded by RBC

Archrock Upgraded by RBC

Archrock received an investment-rating upgrade Wednesday to outperform from sector perform from RBC Capital Markets which cited its some-of-the-parts valuation of the shares following the natural-gas contract-operations company’s better-than-expected Q2 results released earlier this month. The price target is $13 per share, which compares with the stock’s Tuesday closing price of $9.35. In a note to clients, RBC said the sum-of-the-parts valuation is based on the value of Archrock’s limited-partner […]

Read More ˃
NeuroMetrix Gets Sleep-Monitoring Patent

NeuroMetrix Gets Sleep-Monitoring Patent

NeuroMetrix said early Tuesday it has received a patent for a technology whereby the company’s Quell device automatically modulates therapeutic neurostimulation based on the user’s sleep characteristics.In addition, the patent from the U.S. Patent and Trademark Office includes claims related to providing users with feedback about their sleep, the company said in a statement. The company said Quell is the only transcutaneous electrical nerve stimulator cleared by the Food and […]

Read More ˃
Brinker International Fiscal Q4 Tops Views

Brinker International Fiscal Q4 Tops Views

Brinker International shares were higher 4% in pre-market trade after the owner of the Chili’s and Maggiano’s Little Italy restaurant chains reported fiscal Q4 adjusted earnings of $1.09 per share, down from $1.24 in the same period a year ago and topping the estimate of $1.04 from analysts polled by CapIQ. For the quarter ended June 28 total revenues of $810.7 million were down from $881.7 million in the same […]

Read More ˃
Lennox Raises Low End of FY17 Guidance

Lennox Raises Low End of FY17 Guidance

Lennox International, a provider of climate control solutions, reported higher-than-expected results for Q2, and raised the low end of its FY17 guidance. Adjusted EPS from continuing operations increased to $2.83 in the June quarter, from $2.53 a share, in the prior-year quarter. That topped the $2.76 average estimate of analysts surveyed by Capital IQ. Q2 revenue rose 8% to $1.10 billion, beating the analyst consensus of $1.09 billion. The company […]

Read More ˃
Cyclacel Pharmaceuticals Prices Offering

Cyclacel Pharmaceuticals Prices Offering

Cyclacel Pharmaceuticals plunged in pre-market trade Wednesday, after the company priced an underwritten public offering at a discount to Tuesday’s close. The offering is comprised of Class A Units, priced at a public offering price of $2.00 per unit, with each unit consisting of one share of common stock and a seven-year warrant to purchase one share of common stock with an exercise price of $2.00 per share, and Class […]

Read More ˃
Annaly Capital Management Agrees to Sell Pingora Subsidiary

Annaly Capital Management Agrees to Sell Pingora Subsidiary

Annaly Capital Management Inc, a mortgage real estate investment trust, said late Monday that it has agreed to sell its Pingora Loan Servicing subsidiary to Bayview Asset Management, LLC. Pingora operates as a specialized asset manager focused on investing in new production performing mortgage servicing rights and servicing residential mortgage loans. Terms of the transaction were not disclosed. The transaction is expected to close in Q3, subject to customary closing […]

Read More ˃